Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity
- PMID: 15961505
- DOI: 10.1210/me.2005-0042
Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity
Abstract
The steroid hormone 17beta-estradiol (estrogen) plays a significant role in the normal physiology of the mammary gland and breast cancer development primarily through binding to its receptor, the estrogen receptor alpha (ERalpha). ERalpha is a nuclear transcription factor undergoing different types of posttranslational modifications, i.e. phosphorylation, acetylation, and ubiquitination, which regulate its transcriptional activation and/or stability. Here we identify ERalpha as a new target for small ubiquitin-like modifier (SUMO)-1 modification in intact cells and in vitro. Moreover, ERalpha sumoylation occurs strictly in the presence of hormone. SUMO-1 appears to regulate ERalpha-dependent transcription. Using a series of mutants, we demonstrated that ERalpha is sumoylated at conserved lysine residues within the hinge region. Mutations that prevented SUMO modification impaired ERalpha-induced transcription without influencing ERalpha cellular localization. In addition to identifying protein inhibitor of activated signal transducer and activator of transcription (PIAS)1 and PIAS3 as E3 ligases for ERalpha, we also found that PIAS1 and PIAS3, as well as Ubc9, modulated ERalpha-dependent transcription independently from their SUMO-1 conjugation activity. These findings identify sumoylation as a new mechanism modulating ERalpha-dependent cellular response and provide a link between the SUMO and estrogen pathways.
Similar articles
-
SUMO pathway components as possible cancer biomarkers.Future Oncol. 2015;11(11):1599-610. doi: 10.2217/fon.15.41. Future Oncol. 2015. PMID: 26043214 Review.
-
Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.J Biol Chem. 2013 Dec 20;288(51):36312-27. doi: 10.1074/jbc.M113.486845. Epub 2013 Oct 30. J Biol Chem. 2013. PMID: 24174529 Free PMC article.
-
The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.Biol Cell. 2012 May;104(5):287-96. doi: 10.1111/boc.201100116. Epub 2012 Mar 7. Biol Cell. 2012. PMID: 22283414
-
SUMO: getting it on.Biochem Soc Trans. 2007 Dec;35(Pt 6):1409-13. doi: 10.1042/BST0351409. Biochem Soc Trans. 2007. PMID: 18031233 Review.
-
FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.Endocr Res. 2004 Nov;30(4):617-21. doi: 10.1081/erc-200043789. Endocr Res. 2004. PMID: 15666801
Cited by
-
Roles of estrogen receptor α in endometrial carcinoma (Review).Oncol Lett. 2023 Oct 25;26(6):530. doi: 10.3892/ol.2023.14117. eCollection 2023 Dec. Oncol Lett. 2023. PMID: 38020303 Free PMC article. Review.
-
Estrogen Receptor Signaling in Breast Cancer.Cancers (Basel). 2023 Sep 23;15(19):4689. doi: 10.3390/cancers15194689. Cancers (Basel). 2023. PMID: 37835383 Free PMC article. Review.
-
TRIM28 modulates nuclear receptor signaling to regulate uterine function.Nat Commun. 2023 Aug 1;14(1):4605. doi: 10.1038/s41467-023-40395-7. Nat Commun. 2023. PMID: 37528140 Free PMC article.
-
Regulation of SUMOylation on RNA metabolism in cancers.Front Mol Biosci. 2023 Feb 24;10:1137215. doi: 10.3389/fmolb.2023.1137215. eCollection 2023. Front Mol Biosci. 2023. PMID: 36911524 Free PMC article. Review.
-
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653. Cells. 2023. PMID: 36831322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous